Treatment of acute severe asthma & routine management of chronic bronchospasm unresponsive to conventional therapy. Symptomatic relief of an acute attack, as part of the emergency treatment of acute severe asthma & as part of the long-term chronic therapy of asthma.
Adult & childn ≥12 yr 2.5-5 mg or 50-100 drops qid. Childn up to 12 yr 1.25-2.5 mg or 25-50 drops every 4-6 hr as needed. Severe airways obstructionAdult Max of 40 mg/day under strict medical supervision. Use w/ respirator or nebulizer over 5-15 min.
Hyperthyroidism. CV diseases eg, ischemic heart disease, arrhythmia or tachycardia, HTN, occlusive vascular disorders including arteriosclerosis & aneurysms. Anginal pain in patients w/ angina pectoris. May produce rebound congestion & rhinorrhea. Patients w/ DM or closed-angle glaucoma. Avoid in patients undergoing anesth w/ cyclopropane, halothane or other halogenated anesth as may induce ventricular fibrillation. Increased risk of arrhythmias w/ patients receiving cardiac glycosides, quinine or tricyclic antidepressants. Care in patients known to receive large doses of other sympathomimetic drugs. Hypokalemia in severe asthma as may be potentiated by hypoxia or concomitant administration of other antiasthma.
R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Sign Out
